PATENT CLAIM ANALYSIS

Application Number: 16008318
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "400000"]

Abstract:
Disclosed are novel formulations of oral tetraiodothyronine (T4), characterised by the formation in aqueous media of soluble, bioavailable micellar nanoaggregates.

Claim (Index 1):
A method of preparing liquid oral pharmaceutical formulation of tetraiodothyronine, said method comprising:\n solubilizing said tetraiodothyronine in polyethylene glycols 200, 300, 400, or 600 or mixtures thereof in a concentration of from 10 to 250 \u03bcg/ml to obtain soluble micellar nanoaggregates of dimensions ranging from 50 to 200 nm which, when diluted with water, do form insoluble microaggregates.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.08696
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10769980', '13391440', '10392586', '10136433', '10743609']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6326119673641464
- 35 USC 102 Novelty (BERT): 0.4757219614493378
- Combined Prediction Score: 0.6169229667726656
- Mean Citation Score: 86.44744920000002
- Max Citation Score: 90.21584
- Similarity Product: 59.22642846115112

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test